
Financials
Revenue history (in m)
Filing timeliness
1 of 6 financial statements was filed late (for 2021, 46 days late). All were audited by a statutory auditor.
- 202508/07/2026
- 202426/06/2025
- 202327/06/2024
- 202215/06/2023
- 202130/08/2022
- 202030/09/2021
Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.
Statistics
How the company ranks by revenue within its industry, city, voivodeship and across Poland in 2025.
Results vs industry
Industry
Websites
- gsk.comHome | GSKNuxt
Public procurement
715 tenders recorded as contractor: 194 national ($5,999,235) and 521 EU ($736,071,709).
| Publication date | Subject | Amount | Contracting authority | |
|---|---|---|---|---|
| Nov 13, 2026 | Successive supply of vaccines for Szpzlo Warszawa-Wawer, divided into lots | –– | Samodzielny Zespół Publicznych Zakładów Lecznictwa Otwartego Warszawa - Wawer | |
| Nov 13, 2026 | Open tender PN/13PL/06/2026 for the supply of medicinal products and medical devices | $5,717$5,717 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny w Warszawie | |
| Nov 10, 2026 | Supply of vaccines for Mościckie Centrum Medyczne spółka z ograniczoną odpowiedzialnością in Tarnów. | –– | Mościckie Centrum Medyczne sp. z o.o. |
The company is the contractor in 175 public sector contracts, worth USD 116.03m in total. They were signed with 90 public buyers. The largest number (2) were signed with Wojewódzkie Wielospecjalistyczne Centrum Onkologii I Traumatologii Im.M.Kopernika w Łodzi.
| Signed on | Subject | Amount | Public buyer | |
|---|---|---|---|---|
| Nov 12, 2026 | Medicines | $2,563,720 | Uniwersyteckie Centrum Kliniczne | |
| Nov 9, 2026 | Supplies of medicinal products and medical devices | $5,293 | Samodzielny Publiczny Zakład Opieki Zdrowotnej Wojewódzki Szpital Zakaźny w Warszawie | |
| Nov 6, 2026 | Purchase and delivery of mepolizumabum | $89,335 | Uniwersyteckie Centrum Kliniczne Warszawskiego Uniwersytetu Medycznego |
GSK Services has been a party to 7 cases before the National Appeal Chamber (since 2010). It filed 4 appeals (1 upheld, 1 dismissed, 1 discontinued). In 3 cases it joined the proceedings as a participant.
| Date | Subject of dispute | Outcome | Other party | |
|---|---|---|---|---|
| Sep 1, 2026 | Procedure costs | Dismissed | Skarb Państwa – Zakład Zamówień Publicznych przy Ministrze Zdrowia w Warszawie | |
| Nov 20, 2023 | Description of the subject matter of the procurement | Dismissed | Zakład Zamówień Publicznych przy Ministrze Zdrowi | |
| Apr 25, 2023 | Discontinuation of the appeal proceedings | Discontinued | Zakład Zamówień Publicznych przy Ministrze Zdrowia z siedzibą w Warszawie |
Job offers
The company has its own careers page: gsk.com/en-gb/careers.
Authorized Representatives
Manner of representation
For representing the company externally, making declarations of will and signing on behalf of the company, in the case of a one-person management board, the President of the Management Board is authorized to act individually, and in the case of a multi-member management board, the President of the Management Board jointly with a member of the management board, two members of the management board jointly, the President of the Management Board jointly with a commercial proxy, or a member of the management board jointly with a commercial proxy.
Ownership
| Owner | Shares | Share value | Stake |
|---|---|---|---|
| 516,100 | $69,705,564.56 | 100% |
Beneficial owners
| Person | Rights |
|---|---|
Bank accounts
Registered as a VAT taxpayer on 2005-12-30.
51 1030 1335 0000 0005 0399 8500
15 1030 1508 0000 0005 0399 8025
05 1030 1508 0000 0005 0399 8011
Debt
No entries in the National Debtors Register (KRZ).
MSiG notices
| Publication date | Event | |
|---|---|---|
| Sep 15, 2022 | Creditor repayment plan |
Public aid
No public aid cases recorded in the last 10 years.
Regulatory authorisations
| Authority | Type | Status | |
|---|---|---|---|
| BDO register entry | Active |
Competitors
| Name | Revenue | Website | ||
|---|---|---|---|---|
| Roche Polska sp. z o.o. | $799,694,562.77 | roche.pl | ||
| DOZ Direct sp. k. | $767,165,903.98 | doz.pl | ||
| Przedsiębiorstwo Dystrybucji Farmaceutycznej Slawex sp. z o.o. | $600,815,720.02 | slawex.com.pl | ||
| Essity Poland sp. z o.o. | $563,485,192.26 | essity.com | ||
| Salus International sp. z o.o. | $538,709,784.11 | salusint.com.pl | ||
| Hurtap S.A. | $480,276,955.20 | hurtap.com.pl | ||
| Centrala Farmaceutyczna Cefarm S.A. | $457,052,669.59 | cefarm.com.pl | ||
| Bausch Health Poland sp. z o.o. | $433,316,311.35 | bauschhealthpoland.pl | ||
| Komtur Polska sp. z o.o. | $424,362,396.43 | komtur.pl | ||
| Novo Nordisk Pharmaceutical Services sp. z o.o. | $405,739,463.75 | novonordisk.pl |
Change history
| Date | Event | |
|---|---|---|
| 2021-09-29 | Share capital increase (191,050,000.00 PLN → 258,050,000.00 PLN) | |
| 2021-09-29 | PKD change (Removed: 62.03.Z) | |
| 2016-01-20 | PKD change (Removed: 42 codes) | |
| 2010-10-21 | Switch to PKD 2007 (28 PKD 2004 codes → 53 PKD 2007 codes) | |
| 2006-02-27 | Share capital increase (50,000.00 PLN → 191,050,000.00 PLN) |
FAQ
Last updated: 2026-07-15